Effectiveness of remdesivir for the treatment of hospitalized COVID‐19 persons: a network meta‐analysis
Y Jiang, D Chen, D Cai, Y Yi… - Journal of medical …, 2021 - Wiley Online Library
Several randomized clinical trials (RCTs) that investigated the effectiveness of remdesivir for
the treatment of coronavirus disease‐2019 (COVID‐19) have generated inconsistent …
the treatment of coronavirus disease‐2019 (COVID‐19) have generated inconsistent …
The multidimensional challenge of treating coronavirus disease 2019 (COVID-19): remdesivir is a foot in the door
RT Gandhi - Clinical Infectious Diseases, 2021 - academic.oup.com
There are multiple dimensions to consider when treating COVID-19: the severity of infection,
the goals of treatment, and the intervention being deployed. Most people with symptomatic …
the goals of treatment, and the intervention being deployed. Most people with symptomatic …
Current pharmacological treatments for COVID‐19: What's next?
C Scavone, S Brusco, M Bertini… - British journal of …, 2020 - Wiley Online Library
Since December 2019 SARS‐Cov‐2 was found responsible for the disease COVID‐19,
which has spread worldwide. No specific therapies/vaccines are yet available for the …
which has spread worldwide. No specific therapies/vaccines are yet available for the …
[HTML][HTML] COVID-19: An overview and a clinical update
A Krishnan, JP Hamilton, SA Alqahtani… - World journal of clinical …, 2021 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease-2019 (COVID-19, previously known as 2019 nCoV)
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in …
[HTML][HTML] COVID-19: review of epidemiology and potential treatments against 2019 novel coronavirus
An epidemic of extreme respiratory deterrence, pneumonia and shortness of breath, the
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …
SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and …
Ongoing clinical trials for the management of the COVID-19 pandemic
MP Lythgoe, P Middleton - Trends in pharmacological sciences, 2020 - cell.com
COVID-19 has rapidly developed into a worldwide pandemic with a significant health and
economic burden. There are currently no approved treatments or preventative therapeutic …
economic burden. There are currently no approved treatments or preventative therapeutic …
Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
S Juul, EE Nielsen, J Feinberg, F Siddiqui… - PLoS …, 2020 - journals.plos.org
Background Coronavirus disease 2019 (COVID-19) is a rapidly spreading disease that has
caused extensive burden to individuals, families, countries, and the world. Effective …
caused extensive burden to individuals, families, countries, and the world. Effective …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Clinical review of COVID-19; pathogenesis, diagnosis, and management
Severe acute respiratory syndrome-coronavirus (SARS-CoV-2, or COVID-19 virus) is a
worldwide pandemic pathogen infecting 210 territories. It belongs to the family …
worldwide pandemic pathogen infecting 210 territories. It belongs to the family …